Cargando…
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
BACKGROUND: Azithromycin exposure has been reported to increase the risk of QT prolongation and cardiovascular death. However, findings on the association between azithromycin and cardiovascular death are controversial, and azithromycin is still used in actual practice. Additionally, quantitative as...
Autores principales: | Choi, Young, Lim, Hong-Seok, Chung, Dahee, Choi, Jung-gu, Yoon, Dukyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204160/ https://www.ncbi.nlm.nih.gov/pubmed/30406128 http://dx.doi.org/10.1155/2018/1574806 |
Ejemplares similares
-
Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
por: Choi, Byung Jin, et al.
Publicado: (2021) -
Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment
por: Koo, Yeryung, et al.
Publicado: (2023) -
Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data
por: Choi, Byung Jin, et al.
Publicado: (2022) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin: QT interval prolongation: case report
Publicado: (2021)